The technology they invented is incredibly promising for new vaccines and they should be attracting enough investment (through contracts or other deals) to continue innovating and saving lives. Maybe they can license it as a last ditch effort to build revenue, but unfortunately the public perceptions about vaccine efficacy is on the wane and government contracts are no longer there to support this vital work both in the present and as a hedge against future pandemics.
For reference, I get a sore-ish shoulder the next day, and that's it. Also for reference, when I got Actual Covid, I was knocked on my ass for almost two weeks. So for me, at least, the choice is easy.
It's unfortunate that the vaccine has such radically different outcomes within a single household, if it was a flu shot like experience I'd happily get it once per year.
Flu shot experience varies too. The last several have been very low response, but the first few were a miserable couple days and I stopped getting them because certain misery was worse than a chance of misery that I'd never know if it was flu or not, because testing was inaccessible.
COVID-19 may Enduringly Impact Cognitive Performance and Brain Haemodynamics in Undergraduate Students - ScienceDirect https://share.google/49ER4VjJUwipGotZO
When I got Covid later, it was slightly worse chills for 3 days. By the 4th time I got Covid, it was just chills for a day.
If I knew that would be the experience, I'd probably have skipped it. That said, it's completely possible it was having the vaccine that made getting real Covid not so bad.
I'm saying that's not an apples to apples comparison due to the growing evidence of how much long term damage a COVID infection can cause.
I would say people who end up bedridden for 3 days are in the minority for most vaccines immune responses, but people also need to make peace with the idea that an ounce of prevention is worth a pound of cure.
- Plan to sink $180-500M+ just in R&D
- Factor in failures, regulatory, clinical, recruitment, phase 1/2 trials and you arrive very quickly around $1.3-2.1 BILLION USD per therapy approved.
...there is a 90% chance that you will spend that $1B+ - and it will fail completely.
https://www.nature.com/articles/d41573-020-00043-x
https://greenfieldchemical.com/2023/08/10/the-staggering-cos...
Honestly it doesn't sound that bad considering these pharma revenues: https://en.wikipedia.org/wiki/List_of_largest_biomedical_com...
Making pharmaceuticals subservient to the whimsy of the stock market is a bad idea. It introduces incentive distortions where none should be.